Found 75 matching trials
A Study of Paclitaxel Combined With Apatinib and Adebrelimab in Gastric/Gastroesophageal Junction Adenocarcinoma PHASE2 To evaluate the initial efficacy and safety of paclitaxel for injection (al...
Show More Location
The First Affiliated Hospital of Xiamen University
Learn More & Join Trial
SHR-A1811 Alone or in Combination With Adebrelimab as Neoadjuvant Treatment in HR Positive/HER2 Low Breast Cancer PHASE2 This is an open-label, phase II study evaluating the efficacy and safety of...
Show More Location
Shengjing Hospital affiliated to China Medical University
Learn More & Join Trial
Adebrelimab Combined With Chemotherapy for the Esophageal Squamous Cell Carcinoma NA This study is a prospective, single-arm, phase II exploratory clinical tria...
Show More Location
The Second Qilu Hospital of Shandong University
Learn More & Join Trial
A Study on the First-line Treatment of Small Cell Lung Cancer With Adebrelimab and Vunakizumab and Chemotherapy PHASE2 This study is a prospective, single-center, single-arm clinical trial, with...
Show More Location
Multiple Locations
Learn More & Join Trial
A Phase Ib/II Study of Adebrelimab in Combination with Capecitabine and Oxaliplatin in Cancer PHASE1 In this study, the combination of Adebrelimab (PD-L1 monoclonal antibody) o...
Show More Location
Shenzhen Hospital, Cancer Hospital, Chinese Academy of Medical Sciences
Learn More & Join Trial
Phase Ib/II Study of HRS2398 in Combination With Adebrelimab in Patients With Advanced Solid Tumors PHASE1 This study is a multicenter, open-label, dose-finding/efficacy-expanding ph...
Show More Location
Henan Cancer Hospital
Learn More & Join Trial
A Phase III Study of SHR-A1811 in Combination With Chemotherapy and Adebrelimab in Previously Untreated Patients With Gastric or Gastroesophageal Junction Adenocarcinoma PHASE3 This study aims to evaluate the efficacy and safety of SHR-A1811 combined w...
Show More Location
The First Hospital of China Medical University
Learn More & Join Trial
A Phase II Clinical Study of SHR-1826 for Injection in Patients With NSCLC PHASE2 This study is an open-label, multicenter Phase II clinical trial to evaluat...
Show More Location
Chinese People's Liberation Army (PLA) General Hospital
Learn More & Join Trial
A Prospective Study of MSS-type Metastatic Colorectal Cancer Receiving Multiple Lines of Standard Chemotherapy, Bevacizumab Combined With Adebrelimab PHASE2 This study is a prospective, multi-arm, phase II clinical trial that uses t...
Show More Location
Multiple Locations
Learn More & Join Trial
Chemotherapy With or Without Adebrelimab and T-DXh as Neoadjuvant Therapy for HR+/HER2 Low Early Stage Breast Cancer PHASE2 The goal of this clinical trial is to learn if add SHR-A1811 and/or Adebrel...
Show More Location
National Cancer Center/Cancer hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Learn More & Join Trial